FDCTech Reports Over 58% Year-over-Year Revenue Growth in

New Post Public Reply Private Reply Replies (0) Message Board
wayno2
192
FDCTech Reports Over 58% Year-over-Year Revenue Growth in Q1 2025 Driven by Strong Performance Across All Business Segments
Q1 2025 Highlights Show Continued Growth and Operating Profitability.

Irvine, CA, May 14, 2025 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," PINK: FDCT), a fintech-driven firm specializing in acquiring and scaling small to mid-size legacy financial services companies, today announced its unaudited financial results for the three months ended March 31, 2025.

Q1 2025 Financial Highlights

Total Revenue: $10.11 million for Q1 2025, up from $6.38 million in Q1 2024 — an increase of 58.59%, driven primarily by the full-period contribution from the Company’s Investment and Brokerage segment (Alchemy Markets Ltd. and Alchemy Prime Ltd.) and strong performance in the Technology segment.
Gross Profit: $5.18 million in Q1 2025, compared to $2.34 million in Q1 2024 — a growth of 121.32%.
Net Income: $301,002 in Q1 2025, compared to $833,445 in Q1 2024. The prior-year quarter included significant non-operating income.
Cash Position: $26.99 million as of March 31, 2025, up from $24.78 million at year-end 2024.
Working Capital: $10.08 million as of March 31, 2025, up from $9.10 million at year-end 2024.
Net Assets: $15.64 million as of March 31, 2025, up from $14.43 million at year-end 2024.
Performance by Segment

Investment and Brokerage

Revenue rose to $7.76 million in Q1 2025 from $4.61 million in Q1 2024 — an increase of 69%, following full consolidation of AML and APL operations and increased trading volume across European clients.
Wealth Management

Revenue was $1.53 million in Q1 2025, consistent with $1.51 million in Q1 2024, reflecting stable advisor-led revenues at AD Advisory Services.
Technology & Software Development

Revenue grew 218% to $0.81 million in Q1 2025 from $0.26 million in Q1 2024, driven by new licensing agreements and custom development projects for its proprietary Condor Trading platform.
Strategic and Operational Highlights

Condor Investing & Trading App: The Company continues development and expects commercialization.
International Expansion: Opened and staffed new offices in Cyprus, Malta, and the UK. AML continues to onboard EU retail clients and expand product offerings under its MFSA license.
Client Growth: AML now services clients from Germany, France, and other EU countries, including the onboarding of over 2,631 clients from Next Markets and 35 clients from a Cypriot-based broker.
Product Offering Expansion: AML obtained MFSA authorization under Article 6 of the Investment Services Act to offer equities and money market securities, expanding its income-generating capabilities.
FDCTech’s management remains committed to building a diversified and scalable financial services company. With a strong balance sheet, improved operational margins, and growth in core segments, the Company is well-positioned for continued expansion in FY 2025.

Please visit our SEC filings or the Company's website for more information on the full results and management's plan.

FDCTech, Inc.

FDCTech, Inc. ("FDC" is a regulatory-grade financial technology infrastructure developer designed to serve the future financial markets. Our clients include regulated and OTC brokerages and prop and algo trading firms of all sizes in forex, stocks, commodities, indices, ETFs, precious metals, and other asset classes. Our growth strategy involves acquiring and integrating small to mid-size legacy financial services companies, leveraging our proprietary trading technology and liquidity solutions to deliver exceptional value to our clients.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Wingderm USA Expands Its Footprint at 2025 Aesthetic Show

Updated Category News Views 187

Wingderm USA Takes Center Stage at The Aesthetic Show 2025 Wingderm®, an innovative leader in energy-based medical aesthetic technologies, made a significant impact at The Aesthetic Show (TAS) 2025. This event was a pivotal moment in strengthening Wingderm’s position within the U.S. medical aesthetic market. It was held at a renowned venue and brought together medical...

Continue Reading
INVO Bioscience's Strategic Cash Advance Enhances Financial Stability

Updated Category News Views 259

INVO Bioscience Secures Essential Funding INVO Bioscience, Inc. (NASDAQ:INVO), a prominent player in the medical device sector, has recently embarked on a significant financial maneuver to enhance its operational stability. By entering into a Merchant Cash Advance agreement, the company has obtained $265,000, aiming to bolster its working capital and support various...

Continue Reading
FibroGen Secures $160 Million from Sale to AstraZeneca

Updated Category News Views 120

FibroGen Triumphs with Strategic Sale of China Operations FibroGen, Inc. (NASDAQ: FGEN) is making waves in the biopharmaceutical industry with the recent announcement of its agreement to sell its China subsidiary to AstraZeneca for approximately $160 million. This important financial maneuver not only bolsters FibroGen's financial stability but also positions the company...

Continue Reading
Enzoic Teams Up with CIS CyberMarket for Cybersecurity

Updated Category News Views 76

Enzoic Partners with CIS CyberMarket to Strengthen Cybersecurity Enzoic is excited to announce a strategic partnership with CIS CyberMarket, a program designed to enhance the procurement of cybersecurity solutions for various U.S. government entities, nonprofits, and educational institutions. This collaboration aims to provide those organizations with effective,...

Continue Reading
Fosun's Strategic Sale of German Bank Gathers EUR670 Million

Updated Category News Views 589

Fosun International Completes Strategic Sale of HAL Fosun International Limited has successfully finalized the sale of 99.743% of shares in Hauck Aufhäuser Lampe Privatbank AG (HAL), bringing in EUR670 million. This strategic transaction is a significant part of Fosun's ongoing initiatives to optimize its portfolio and focus on core growth sectors. Transforming Private...

Continue Reading